Registered entities
Soligenix, Inc.
Reg. No. 812796United States
SOLIGENIX, INC
Reg. No. 41-1505029United States
Innovation
27 patent families (16 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 888 times.
| Year | Filings |
|---|---|
| 2014 | 6 |
| 2015 | 6 |
| 2016 | 5 |
| 2017 | 9 |
| 2018 | 7 |
| 2019 | 8 |
| 2020 | 7 |
| 2021 | 5 |
| 2022 | 4 |
| 2023 | 8 |
| 2024 | 6 |
| 2025 | 4 |
Social engagement
Social engagement: 7K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
16 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 19% |
| Private equity | 1 | 6% |
| Bank & private debt | 1 | 6% |
| Other / undisclosed | 11 | 69% |
Recent activity
26 Mar 2026
Recognition
19 Mar 2026
Product launch
HyBryteTM Clinical Summary
6 Feb 2026
Product launch
$SNGX SGX945